Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

Pattern of Interleukin-17A and Interleukin-1β in Migraine Patients

Document Type : Original Article

Authors

1 Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran

2 Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran

3 Department of Health and Nutrition, Islamic Azad University Arak Branch, Arak, Iran.

4 Department of Neurology, University of California, San Diego, USA

5 Department of Biostatistics and Epidemiology, School of Health, Tehran University of Medical Sciences, Tehran, Iran

6 Student research committee, Arak University of Medical Sciences, Arak, Iran

7 Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Irann

Abstract

Background: Migraine is a complex neurological disorder. The precise etiology of migraine is not clear. Many studies have been conducted on the association of the immune system with migraine pathophysiology. Neurogenic inflammation, the main pathomechanism of migraine, is well described. This study evaluated the pattern of changes in interleukin (IL)-1β, IL-17A, total antioxidant capacity (TAC), and malondialdehyde (MDA) in migraine patients.
Methods: In this case-control study, serum samples were taken from 31 migraine patients referred to the neurology clinics of medical centers associated with Arak University of Medical Sciences. The severity of the headache was assessed with standard questionnaires. Serum samples were also obtained from 30 normal individuals. The IL-1β and IL-17A levels were measured by a sensitive ELISA method. TAC was measured by the FRAP technique, and lipid peroxidation levels were evaluated by an MDA assay. Data were analyzed descriptively and analytically using SPSS 21 software.
Results: The results showed that the mean level of IL-1β in the case group was significantly higher than the control group (P = 0.01). The mean level of IL-17A was not significantly different in the two groups. The mean serum MDA level in the study group was significantly higher than in the controls (P = 0.005). No statistical difference was observed in the mean serum level of TAC between the two groups.
Conclusion: According to our results, the pathogenesis of migraine can be associated with immune system function, and inhibition of pro-inflammatory cytokine production may be effective in treating migraine patients.

Keywords

Main Subjects

References
  1. Blumenfeld A. Clinical approaches to migraine prophylaxis. Am J Manag Care. 2005;11(2 Suppl):S55-61.
  2. Buzzi MG, Cologno D, Formisano R. Migraine disease: evolution and progression. J Headache Pain. 2005;6(4):304-6. doi: 10.1007/s10194-005-0215-9.
  3. Parashar R, Bhalla P, Rai NK, Pakhare A, Babbar R. Migraine: is it related to hormonal disturbances or stress? Int J Womens Health. 2014;6:921-5. doi: 10.2147/ijwh.s62922.
  4. Iliopoulos P, Damigos D, Kerezoudi E, Limpitaki G, Xifaras M, Skiada D, et al. Trigger factors in primary headaches subtypes: a cross-sectional study from a tertiary centre in Greece. BMC Res Notes. 2015;8:393. doi: 10.1186/s13104-015-1390-7.
  5. Özturan A, Şanlıer N, Coşkun Ö. The relationship between migraine and nutrition. Turk J Neurol. 2016;22(2):44-50.
  6. Bruno PP, Carpino F, Carpino G, Zicari A. An overview on immune system and migraine. Eur Rev Med Pharmacol Sci. 2007;11(4):245-8.
  7. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol. 2009;8(7):679-90. doi: 10.1016/s1474- 4422(09)70090-0.
  8. Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2010;30(2):120-30. doi: 10.1055/s-0030-1249222.
  9. Borkum JM. Migraine triggers and oxidative stress: a narrative review and synthesis. Headache. 2016;56(1):12-35. doi: 10.1111/head.12725.
  10. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol. 2012;33(1):116-25. doi: 10.1016/j.yfrne.2011.12.002.
  11. Deverman BE, Patterson PH. Cytokines and CNS development. Neuron. 2009;64(1):61-78. doi: 10.1016/j. neuron.2009.09.002.
  12. Smith RS. The cytokine theory of headache. Med Hypotheses. 1992;39(2):168-74. doi: 10.1016/0306-9877(92)90181-b.
  13. Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, et al. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45(7):926-31. doi: 10.1111/j.1526- 4610.2005.05135.x.
  14. Fidan I, Yüksel S, Ymir T, Irkeç C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol. 2006;171(1-2):184-8. doi: 10.1016/j.jneuroim.2005.10.005.
  15. Boćkowski L, Sobaniec W, Zelazowska-Rutkowska B. Proinflammatory plasma cytokines in children with migraine. Pediatr Neurol. 2009;41(1):17-21. doi: 10.1016/j. pediatrneurol.2009.02.001.
  16. de Oliveira CM, Sakata RK, Issy AM, Gerola LR, Salomão R. Cytokines and pain. Rev Bras Anestesiol. 2011;61(2):255-9. doi: 10.1016/s0034-7094(11)70029-0.
  17. Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br J Anaesth. 2001;87(1):3-11. doi: 10.1093/bja/87.1.3.
  18. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 1997;121(3):417-24. doi: 10.1038/ sj.bjp.0701148.
  19. Jin W, Dong C. IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect. 2013;2(1):1-5. doi: 10.1038/ emi.2013.58.
  20. Yamaguchi Y, Fujio K, Shoda H, Okamoto A, Tsuno NH, Takahashi K, et al. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J Immunol. 2007;179(10):7128-36. doi: 10.4049/jimmunol.179.10.7128.
  21. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae Microbes Infect. 2007;9(1):78-86. doi: 10.1016/j.micinf.2006.10.012.
  22. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-21. doi: 10.1016/0076-6879(90)86134-h.
  23. Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15-27. doi: 10.1016/s0076- 6879(99)99005-5.
  24. Dalla Libera D, Di Mitri D, Bergami A, Centonze D, Gasperini C, Grasso MG, et al. T regulatory cells are markers of disease activity in multiple sclerosis patients. PLoS One. 2011;6(6):e21386. doi: 10.1371/journal.pone.0021386.
  25. Geyik S, Altunısık E, Neyal AM, Taysi S. Oxidative stress and DNA damage in patients with migraine. J Headache Pain. 2016;17:10. doi: 10.1186/s10194-016-0606-0.
  26. Eren Y, Dirik E, Neşelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg. 2015;115(4):643-9. doi: 10.1007/ s13760-015-0427-y.
  27. Togha M, Razeghi Jahromi S, Ghorbani Z, Ghaemi A, Rafiee P. An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study. BMC Neurol. 2019;19(1):323. doi: 10.1186/s12883-019-1555-4.
  28. Khosravi A, Nakhaee A, Ghoreishi A, Arefpoor Z, Sadeghi M. Impaired oxidative-antioxidative balance during migraine attack. Biomed Res Ther. 2019;6(2):2996-3002. doi: 10.15419/bmrat.v6i2.522.
  29. Kemper RH, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia. 2001;21(5):549-57. doi: 10.1046/j.1468-2982.2001.00196.x.
  30. Martelletti P, Stirparo G, Morrone S, Rinaldi C, Giacovazzo M. Inhibition of intercellular adhesion molecule-1 (ICAM-1), soluble ICAM-1 and interleukin-4 by nitric oxide expression in migraine patients. J Mol Med (Berl). 1997;75(6):448-53. doi: 10.1007/s001090050130.
  31. Mueller L, Gupta AK, Stein TP. Deficiency of tumor necrosis factor alpha in a subclass of menstrual migraineurs. Headache. 2001;41(2):129-37. doi: 10.1046/j.1526- 4610.2001.111006129.x.
  32. Munno I, Centonze V, Marinaro M, Bassi A, Lacedra G, Causarano V, et al. Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache. 1998;38(6):465-7. doi: 10.1046/j.1526-4610.1998.3806465.x.
  33. Faraji F, Shojapour M, Farahani I, Ganji A, Mosayebi G. Reduced regulatory T lymphocytes in migraine patients. Neurol Res. 2021;43(8):677-82. doi: 10.1080/01616412.2021.1915077.
  34. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8(3):223-46.
  35. Neeb L, Hellen P, Boehnke C, Hoffmann J, Schuh-Hofer S, Dirnagl U, et al. IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One. 2011;6(3):e17360. doi: 10.1371/journal.pone.0017360.
  36. Bromander S, Anckarsäter R, Kristiansson M, Blennow K, Zetterberg H, Anckarsäter H, et al. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation. 2012;9:242. doi: 10.1186/1742-2094-9-242.
  37. Yoon HJ, Lee MS, Ki M, Ihm C, Kim D, Kim Y, et al. Does IL- 17 play a role in hepatic dysfunction of scrub typhus patients? Vector Borne Zoonotic Dis. 2010;10(3):231-5. doi: 10.1089/ vbz.2008.0149.
Journal of Kerman University of Medical Sciences
Volume 31, Issue 4
July and August 2024
Pages 199-203
Files
Share
How to cite
Statistics